If you don't remember your password, you can reset it by entering your email address and clicking the Reset Password button. You will then receive an email that contains a secure link for resetting your password
If the address matches a valid account an email will be sent to __email__ with instructions for resetting your password
In the current issue, we explore the cause, implications, and possible strategies to address these tragic racial, social, and financial disparities as they pertain to the diagnosis and management of CRC.
The management paradigm of CRC has evolved significantly over the last century since Miles’ original description of the extralevator abdominoperineal resection with an accompanying 41% mortality rate.
Innovative endoscopic and transanal techniques along with advancements in novel therapeutic agents have led to substantial improvements in oncologic and patient-reported outcomes with increasing rates of sphincter preservation. In the current issue, we learn from the world’s experts, who are leading this innovative renaissance.
As history demonstrates, controversy frequently lies in the shadow of innovation. Two particularly controversial topics in the surgical treatment of CRC focus on the technical aspects of the mesenteric excision: (1) the complete mesocolic excision and extent of lymphadenectomy for colon cancer, and (2) the minimally invasive total mesorectal excision (laparoscopy, robotics, transanal) for rectal cancer. We delve into both of these important topics, hearing from highly skilled surgeons in the technical and practice aspects of each of these evolving techniques.
In the current issue of Surgical Oncology Clinics of North America, we sought to highlight the most important surgical aspects of CRC management. I am inspired by and thankful to my esteemed colleagues, who contributed their expertise to the current issue, and I hope you will gain valuable information to improve your practice.
CDC. Expected New Cancer Cases and Deaths in 2020. 2016.